George S. Watts
Department of Medical Pharmacology
College of Medicine
University of Arizona
Tucson AZ 85724 USA
USA
Name/email consistency: high
- DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage. Watts, G.S., Futscher, B.W., Holtan, N., Degeest, K., Domann, F.E., Rose, S.L. BMC. Med. Genomics (2008)
- Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma. Watts, G.S., Tran, N.L., Berens, M.E., Bhattacharyya, A.K., Nelson, M.A., Montgomery, E.A., Sampliner, R.E. Int. J. Cancer (2007)
- The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells. Watts, G.S., Oshiro, M.M., Junk, D.J., Wozniak, R.J., Watterson, S., Domann, F.E., Futscher, B.W. Neoplasia (2004)
- cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. Watts, G.S., Futscher, B.W., Isett, R., Gleason-Guzman, M., Kunkel, M.W., Salmon, S.E. J. Pharmacol. Exp. Ther. (2001)